{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:01:21Z","timestamp":1793991681422,"version":"4.8.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T00:00:00Z","timestamp":1334620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/nrneph.2012.81","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T11:52:46Z","timestamp":1334663566000},"page":"348-357","source":"Crossref","is-referenced-by-count":349,"title":["The impact of donor-specific anti-HLA antibodies on late kidney allograft failure"],"prefix":"10.1038","volume":"8","author":[{"given":"Alexandre","family":"Loupy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,17]]},"reference":[{"key":"BFnrneph201281_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJM198502283120905","volume":"312","author":"RW Evans","year":"1985","unstructured":"Evans, R. W. et al. The quality of life of patients with end-stage renal disease. N. Engl. J. Med. 312, 553\u2013559 (1985).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201281_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","volume":"270","author":"FK Port","year":"1993","unstructured":"Port, F. K., Wolfe, R. A., Mauger, E. A., Berling, D. P. & Jiang, K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 270, 1339\u20131343 (1993).","journal-title":"JAMA"},{"key":"BFnrneph201281_CR3","unstructured":"L'Agence de la biom\u00e9decine. Agence de la Biom\u00e9decine Annual Report [online] , (2011)."},{"key":"BFnrneph201281_CR4","unstructured":"Organ Procurement and Transplantation Network [online] , (2012)."},{"key":"BFnrneph201281_CR5","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","volume":"15","author":"SC Jordan","year":"2004","unstructured":"Jordan, S. C. et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J. Am. Soc. Nephrol. 15, 3256\u20133262 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR6","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","volume":"9","author":"G Einecke","year":"2009","unstructured":"Einecke, G. et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am. J. Transplant. 9, 2520\u20132531 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"J Sellares","year":"2012","unstructured":"Sellares, J. et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am. J. Transplant. 12, 388\u2013399 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","volume":"90","author":"RS Gaston","year":"2010","unstructured":"Gaston, R. S. et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90, 68\u201374 (2010).","journal-title":"Transplantation"},{"key":"BFnrneph201281_CR9","unstructured":"United States Renal Data System. USRDS Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States [online] , (2010)."},{"key":"BFnrneph201281_CR10","unstructured":"Fields, R. In Dialysis, Life-Saving Care at Great Risk and Cost. ProPublica [online] , (2010)."},{"key":"BFnrneph201281_CR11","doi-asserted-by":"crossref","unstructured":"United Network for Organ Sharing [online] , (2011).","DOI":"10.1016\/j.ycar.2011.04.010"},{"key":"BFnrneph201281_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJMoa0707894","volume":"359","author":"AA Vo","year":"2008","unstructured":"Vo, A. A. et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N. Engl. J. Med. 359, 242\u2013251 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201281_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","volume":"89","author":"AA Vo","year":"2010","unstructured":"Vo, A. A. et al. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation 89, 1095\u20131102 (2010).","journal-title":"Transplantation"},{"key":"BFnrneph201281_CR14","unstructured":"Scientific Registry of Transplant Recipients [online] , (2011)."},{"key":"BFnrneph201281_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1600-6143.2011.03830.x","volume":"12","author":"N Kohei","year":"2012","unstructured":"Kohei, N., Hirai, T., Omoto, K., Ishida, H. & Tanabe, K. Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period. Am. J. Transplant. 12, 469\u2013476 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR16","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","volume":"89","author":"A Loupy","year":"2010","unstructured":"Loupy, A. et al. Combined posttransplant prophylactic IVIg\/anti-CD 20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study. Transplantation 89, 1403\u20131410 (2010).","journal-title":"Transplantation"},{"key":"BFnrneph201281_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2215\/CJN.08140910","volume":"6","author":"K Marfo","year":"2011","unstructured":"Marfo, K., Lu, A., Ling, M. & Akalin, E. Desensitization protocols and their outcome. Clin. J. Am. Soc. Nephrol. 6, 922\u2013936 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR18","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","volume":"11","author":"P Archdeacon","year":"2011","unstructured":"Archdeacon, P. et al. Summary of FDA antibody-mediated rejection workshop. Am. J. Transplant. 11, 896\u2013906 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","volume":"2","author":"D Glotz","year":"2002","unstructured":"Glotz, D. et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am. J. Transplant. 2, 758\u2013760 (2002).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1056\/NEJMoa1012376","volume":"365","author":"RA Montgomery","year":"2011","unstructured":"Montgomery, R. A. et al. Desensitization in HLA-incompatible kidney recipients and survival. N. Engl. J. Med. 365, 318\u2013326 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201281_CR21","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1111\/j.1600-6143.2010.03268.x","volume":"10","author":"PF Halloran","year":"2010","unstructured":"Halloran, P. F. et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am. J. Transplant. 10, 2223\u20132230 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR22","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","volume":"9","author":"LG Hidalgo","year":"2009","unstructured":"Hidalgo, L. G. et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am. J. Transplant. 9, 2532\u20132541 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1681\/ASN.2009101065","volume":"21","author":"C Lefaucheur","year":"2010","unstructured":"Lefaucheur, C. et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J. Am. Soc. Nephrol. 21, 1398\u20131406 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR24","first-page":"1","volume":"162","author":"C Lefaucheur","year":"2009","unstructured":"Lefaucheur, C. et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib. Nephrol. 162, 1\u201312 (2009).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph201281_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","volume":"7","author":"K Solez","year":"2007","unstructured":"Solez, K. et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am. J. Transplant. 7, 518\u2013526 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR26","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","volume":"7","author":"JM Gloor","year":"2007","unstructured":"Gloor, J. M. et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am. J. Transplant. 7, 2124\u20132132 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR27","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","volume":"7","author":"B Sis","year":"2007","unstructured":"Sis, B. et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am. J. Transplant. 7, 1743\u20131752 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR28","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1681\/ASN.2007010073","volume":"18","author":"RB Colvin","year":"2007","unstructured":"Colvin, R. B. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J. Am. Soc. Nephrol. 18, 1046\u20131056 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez, K. et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am. J. Transplant. 8, 753\u2013760 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","volume":"10","author":"B Sis","year":"2010","unstructured":"Sis, B. et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am. J. Transplant. 10, 464\u2013471 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MOT.0b013e3283342712","volume":"15","author":"MD Stegall","year":"2010","unstructured":"Stegall, M. D. & Gloor, J. M. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment. Curr. Opin. Organ Transplant. 15, 8\u201310 (2010).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"BFnrneph201281_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/TP.0b013e3181856f98","volume":"86","author":"NL Reinsmoen","year":"2008","unstructured":"Reinsmoen, N. L. et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 86, 820\u2013825 (2008).","journal-title":"Transplantation"},{"key":"BFnrneph201281_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/TP.0b013e31821eab8a","volume":"92","author":"CH Lai","year":"2011","unstructured":"Lai, C. H. et al. Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy. Transplantation 92, 48\u201353 (2011).","journal-title":"Transplantation"},{"key":"BFnrneph201281_CR34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-6143.2007.02017.x","volume":"8","author":"AA Vo","year":"2008","unstructured":"Vo, A. A. et al. Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab. Am. J. Transplant. 8, 144\u2013149 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR35","doi-asserted-by":"publisher","unstructured":"Smith, R. N. & Colvin, R. B. Chronic alloantibody mediated rejection. Semin. Immunol. http:\/\/dx.doi.org\/10.1016\/j.smim.2011.09.002 .","DOI":"10.1016\/j.smim.2011.09.002"},{"key":"BFnrneph201281_CR36","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2215\/CJN.08140910","volume":"6","author":"K Marfo","year":"2011","unstructured":"Marfo, K., Lu, A., Ling, M. & Akalin, E. Desensitization protocols and their outcome. Clin. J. Am. Soc. Nephrol. 6, 922\u2013936 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","volume":"12","author":"T Hirohashi","year":"2012","unstructured":"Hirohashi, T. et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am. J. Transplant. 12, 313\u2013321 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR38","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","volume":"10","author":"LG Hidalgo","year":"2010","unstructured":"Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transplant. 10, 1812\u20131822 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1586\/eci.11.10","volume":"7","author":"SC Jordan","year":"2011","unstructured":"Jordan, S. C., Toyoda, M. & Vo, A. A. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Expert Rev. Clin. Immunol. 7, 341\u2013348 (2011).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrneph201281_CR40","first-page":"125","volume":"10","author":"JL Platt","year":"2010","unstructured":"Platt, J. L. Antibodies in transplantation. Discov. Med. 10, 125\u2013133 (2010).","journal-title":"Discov. Med."},{"key":"BFnrneph201281_CR41","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MOT.0b013e32834874f7","volume":"16","author":"SC Jordan","year":"2011","unstructured":"Jordan, S. C., Kahwaji, J., Toyoda, M. & Vo, A. B-cell immunotherapeutics: emerging roles in solid organ transplantation. Curr. Opin. Organ Transplant. 16, 416\u2013424 (2011).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"BFnrneph201281_CR42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.V123574","volume":"12","author":"S Mauiyyedi","year":"2001","unstructured":"Mauiyyedi, S. et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J. Am. Soc. Nephrol. 12, 574\u2013582 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR43","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/j.1600-6143.2006.01351.x","volume":"6","author":"RN Smith","year":"2006","unstructured":"Smith, R. N. et al. Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates. Am. J. Transplant. 6, 1790\u20131798 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR44","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","volume":"9","author":"A Loupy","year":"2009","unstructured":"Loupy, A. et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am. J. Transplant. 9, 2561\u20132570 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000170814","volume":"162","author":"RB Colvin","year":"2009","unstructured":"Colvin, R. B. Pathology of chronic humoral rejection. Contrib. Nephrol. 162, 75\u201386 (2009).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph201281_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-6143.2010.03364.x","volume":"11","author":"A Loupy","year":"2011","unstructured":"Loupy, A. et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am. J. Transplant. 11, 56\u201365 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR47","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2249.1991.tb02954.x","volume":"86","author":"HE Feucht","year":"1991","unstructured":"Feucht, H. E. et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin. Exp. Immunol. 86, 464\u2013470 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph201281_CR48","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/ki.1993.187","volume":"43","author":"HE Feucht","year":"1993","unstructured":"Feucht, H. E. et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int. 43, 1333\u20131338 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph201281_CR49","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1097\/01.ASN.0000025780.03790.0F","volume":"13","author":"H Regele","year":"2002","unstructured":"Regele, H. et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J. Am. Soc. Nephrol. 13, 2371\u20132380 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR50","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1600-6143.2006.01657.x","volume":"7","author":"M Haas","year":"2007","unstructured":"Haas, M. et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am. J. Transplant. 7, 576\u2013585 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR51","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/01.tp.0000266676.10550.70","volume":"83","author":"E Lerut","year":"2007","unstructured":"Lerut, E., Naesens, M., Kuypers, D. R., Vanrenterghem, Y. & Van Damme, B. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplantation 83, 1416\u20131422 (2007).","journal-title":"Transplantation"},{"key":"BFnrneph201281_CR52","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","volume":"9","author":"B Sis","year":"2009","unstructured":"Sis, B. et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am. J. Transplant. 9, 2312\u20132323 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR53","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V1341091","volume":"13","author":"GA Bohmig","year":"2002","unstructured":"Bohmig, G. A. et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J. Am. Soc. Nephrol. 13, 1091\u20131099 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR54","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1111\/j.1600-6143.2009.02836.x","volume":"9","author":"A Haririan","year":"2009","unstructured":"Haririan, A. et al. The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am. J. Transplant. 9, 2758\u20132767 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1600-6143.2009.02555.x","volume":"9","author":"RL Kedainis","year":"2009","unstructured":"Kedainis, R. L., Koch, M. J., Brennan, D. C. & Liapis, H. Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival. Am. J. Transplant. 9, 812\u2013819 (2009).","journal-title":"Am. J. Transplant."},{"issue":"Suppl.","key":"BFnrneph201281_CR56","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.healun.2011.01.035","volume":"30","author":"A Loupy","year":"2011","unstructured":"Loupy, A. et al. Performance of routine C4d and C3d immunostaining on protocol EMBs in a prospective and unselected cohort of heart transplant patients. J. Heart Lung Transplant. 30 (Suppl.), S17 (2011).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrneph201281_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MOT.0b013e3283352a50","volume":"15","author":"B Sis","year":"2010","unstructured":"Sis, B. & Halloran, P. F. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr. Opin. Organ Transplant. 15, 42\u201348 (2010).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"BFnrneph201281_CR58","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","volume":"12","author":"M Mengel","year":"2012","unstructured":"Mengel, M. et al. Banff 2011 Meeting Report: new concepts in antibody-mediated rejection. Am. J. Transplant. 12, 563\u2013570 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR59","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/j.1600-6143.2011.03647.x","volume":"11","author":"M Haas","year":"2011","unstructured":"Haas, M. & Mirocha, J. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am. J. Transplant. 11, 2123\u20132131 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR60","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1111\/j.1600-6143.2007.01995.x","volume":"7","author":"MD Wavamunno","year":"2007","unstructured":"Wavamunno, M. D. et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am. J. Transplant. 7, 2757\u20132768 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR61","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/j.1600-6143.2008.02262.x","volume":"8","author":"J Gloor","year":"2008","unstructured":"Gloor, J., Cosio, F., Lager, D. J. & Stegall, M. D. The spectrum of antibody-mediated renal allograft injury: implications for treatment. Am. J. Transplant. 8, 1367\u20131373 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR62","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/j.1600-6143.2006.01416.x","volume":"6","author":"JM Gloor","year":"2006","unstructured":"Gloor, J. M. et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am. J. Transplant. 6, 1841\u20131847 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1600-6143.2009.02938.x","volume":"10","author":"B Sis","year":"2010","unstructured":"Sis, B. et al. Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am. J. Transplant. 10, 421\u2013430 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR64","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","volume":"55","author":"LC Racusen","year":"1999","unstructured":"Racusen, L. C. et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55, 713\u2013723 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph201281_CR65","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1681\/ASN.2010070777","volume":"22","author":"GS Hill","year":"2011","unstructured":"Hill, G. S. et al. Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J. Am. Soc. Nephrol. 22, 975\u2013983 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MOT.0b013e3283342684","volume":"15","author":"GS Hill","year":"2010","unstructured":"Hill, G. S., Nochy, D. & Loupy, A. Accelerated arteriosclerosis: a form of transplant arteriopathy. Curr. Opin. Organ Transplant. 15, 11\u201315 (2010).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"BFnrneph201281_CR67","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens, M., Kuypers, D. R. & Sarwal, M. Calcineurin inhibitor nephrotoxicity. Clin. J. Am. Soc. Nephrol. 4, 481\u2013508 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR68","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(86)90355-7","volume":"2","author":"JJ Curtis","year":"1986","unstructured":"Curtis, J. J. et al. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 2, 477\u2013479 (1986).","journal-title":"Lancet"},{"key":"BFnrneph201281_CR69","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2215\/CJN.03820609","volume":"4","author":"RS Gaston","year":"2009","unstructured":"Gaston, R. S. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clin. J. Am. Soc. Nephrol. 4, 2029\u20132034 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201281_CR70","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/ki.1986.280","volume":"30","author":"BD Myers","year":"1986","unstructured":"Myers, B. D. Cyclosporine nephrotoxicity. Kidney Int. 30, 964\u2013974 (1986).","journal-title":"Kidney Int."},{"key":"BFnrneph201281_CR71","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa020009","volume":"349","author":"BJ Nankivell","year":"2003","unstructured":"Nankivell, B. J. et al. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349, 2326\u20132333 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201281_CR72","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1600-6143.2011.03505.x","volume":"11","author":"AJ Matas","year":"2011","unstructured":"Matas, A. J. Chronic progressive calcineurin nephrotoxicity: an overstated concept. Am. J. Transplant. 11, 687\u2013692 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR73","first-page":"303","volume":"17","author":"M Mihatsch","year":"1988","unstructured":"Mihatsch, M., Thiel, G. & Ryffel, B. Cyclosporine nephrotoxicity. Adv. Nephrol. Necker Hosp. 17, 303\u2013320 (1988).","journal-title":"Adv. Nephrol. Necker Hosp."},{"key":"BFnrneph201281_CR74","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1111\/j.1600-6143.2011.03718.x","volume":"11","author":"R Snanoudj","year":"2011","unstructured":"Snanoudj, R. et al. Specificity of histological markers of long-term CNI nephrotoxicity in kidney transplant recipients under low-dose cyclosporine therapy. Am. J. Transplant. 11, 2635\u20132646 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR75","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","volume":"11","author":"MD Stegall","year":"2011","unstructured":"Stegall, M. D. et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am. J. Transplant. 11, 2405\u20132413 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201281_CR76","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2011)."},{"key":"BFnrneph201281_CR77","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2011)."},{"key":"BFnrneph201281_CR78","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2012.81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2012.81","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2012.81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T01:37:36Z","timestamp":1687397856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2012.81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,17]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFnrneph201281"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2012.81","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,17]]}}}